The new proposed FDA warnings include acetaminophen and non-steroidal anti-inflammatory medications, or NSAIDs, including aspirin, naproxen and ibuprofen. Including some of the most popular over the counter drugs including Tylenol, Aleve, Motrin and Advil. According to the story, the FDA warnings would, "include important safety information regarding the potential for stomach bleeding and liver damage and when to see a health care provider."
A Washington-based consumer advocacy group, the Public Citizen, claims that the warnings have come several years later than they should have. In 2002 federal advisers to the FDA had called for similar label changes. Dr. Paul Watkins, a professor of medicine at The University of North Carolina at Chapel Hill and a member of the 2002 advisory panel commented, "It's a step that's overdue and truly reflects the consensus that came out of the meeting four years ago, that is helping the consumer know what they are consuming."
The media reports on this issue report on the scale of this problem noting that 48 million Americans take an acetaminophen products weekly. Some 56,000 people end up in the hospital annually from problems associated to this drug, and about 100 people die each year after unintentionally overdosing. The recommended FDA labels would warn of the risk of severe liver damage for patients consuming more than the recommended medication dosage or who consume three or more alcoholic beverages per day while you're on the drugs. The FDA would also warn individuals not to take multiple medicines which contain acetaminophen.
As far as aspirin, ibuprofen, naproxen along with other nonsteroidal anti-inflammatory drugs, the additional FDA warnings would stress the risk of stomach bleeding. According to the article, 17 million Americans take an NSAID daily. These drugs, sold as aspirin, Advil and Motrin and Aleve as well as in generic forms, send more than 200,000 Americans to the hospital yearly, and are linked to 16,000 deaths.